Hypoxic conditioned culture medium from fibroblasts grown under embryonic-like conditions supports healing following post-laser resurfacing

Journal of Cosmetic Dermatology

Volumn 8, Issue 3, 2009, Pages 190-196

  Kellar, Robert S ^a,c   Hubka, Mark ^a   Rheins, Lawrence A ^a   Fisher, Garth ^b   Naughton, Gail K ^a  

^a Histogen Inc ^*  (United States)

^b Biomedical Skin Treatment Institute   (United States)

^c NONE   (United States)

Author keywords

Cosmetic procedure; Erythema; Extracellular matrix; Laser treatment; Tissue engineering; Wound healing

Indexed keywords

PETROLATUM; PLACEBO; REGENICA; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ADULT; AGED; ARTICLE; CELL GROWTH; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG USE; EPITHELIZATION; ERYTHEMA; ESTHETICS; FACE EDEMA; FIBROBLAST CULTURE; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LOTION; LOW LEVEL LASER THERAPY; MEDICAL PHOTOGRAPHY; MICROARRAY ANALYSIS; NORMAL HUMAN; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; SKIN ABRASION; SKIN ALLERGY; SKIN EDEMA; SKIN EXFOLIATION; SKIN INJURY; SKIN IRRITATION; SKIN MANIFESTATION; WOUND HEALING;

BIOREACTORS; CELL HYPOXIA; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; FIBROBLAST GROWTH FACTOR 7; FIBROBLASTS; HUMANS; INTERLEUKIN-8; LASER THERAPY; REGENERATION; SAFETY; TISSUE THERAPY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 70149121499     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00454.x     Document Type: Article

References (12)

1. Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-7.
2. Walsh JT Jr, Flotte TJ, Anderson RR, Deutsch TF. Pulsed CO 2 laser tissue ablation: Effect of tissue type and pulse duration on thermal damage. Lasers Surg Med 1988; 8: 108-18.
3. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: Nonablative, fractional and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719-37.
4. Cosmetic Surgery National Data Bank Statistics. The American Society for Aesthetic Plastic Surgery, CA, USA: 2007.
5. Fulton JE. Complications of laser resurfacing. Methods of prevention and management. Dermatol Surg 1998; 24: 91-9.
6. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care 1998; 11(Suppl. 4): 1-8.
7. Mansbridge J, Liu K, Pinney E, Patch R, Ratcliffe A, Naughton GK. Growth factors secreted by fibroblasts: Role in healing diabetic foot ulcers. Diabetes Obes Metab 1999; 1: 265.
8. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 1997; 21: 1203.
9. Demling RH, DeSanti L. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes). Burn 1999; 25: 256-61.
10. Clark RAF. Overview and general considerations of wound repair. In: Clark RAF, Henson PM, eds. The Molecular and Cellular Biology of Wound Repair. New YoPk: Plenum Press. 1996: pp. 3-33.
11. Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994; 220: 10-8.
12. Sulimovic L, Licu D, Ledo E, Naeyaert JM, Pigatto P, Tzermias C, Vasquez Doval J, Dupuy P. Efficacy and safety of a topically applied Avène spring water spray in the healing of facial skin after laser resurfacing. Dermatol Surg 2002; 5: 415-8.